Logo image of CMT

CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis

NYSEARCA:CMT - NYSE Arca - US2186831002 - Common Stock - Currency: USD

17.35  -0.12 (-0.69%)

Fundamental Rating

6

CMT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. CMT has an excellent financial health rating, but there are some minor concerns on its profitability. CMT is cheap, but on the other hand it scores bad on growth. These ratings would make CMT suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CMT had positive earnings in the past year.
In the past year CMT had a positive cash flow from operations.
Each year in the past 5 years CMT has been profitable.
Each year in the past 5 years CMT had a positive operating cash flow.
CMT Yearly Net Income VS EBIT VS OCF VS FCFCMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

CMT has a better Return On Assets (4.25%) than 76.47% of its industry peers.
CMT's Return On Equity of 6.10% is fine compared to the rest of the industry. CMT outperforms 68.24% of its industry peers.
CMT has a Return On Invested Capital of 5.81%. This is in the better half of the industry: CMT outperforms 64.71% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMT is above the industry average of 6.53%.
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROIC 5.81%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
CMT Yearly ROA, ROE, ROICCMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

The Profit Margin of CMT (3.39%) is better than 62.35% of its industry peers.
In the last couple of years the Profit Margin of CMT has grown nicely.
CMT's Operating Margin of 4.89% is on the low side compared to the rest of the industry. CMT is outperformed by 62.35% of its industry peers.
In the last couple of years the Operating Margin of CMT has grown nicely.
CMT has a Gross Margin of 17.50%. This is in the lower half of the industry: CMT underperforms 70.59% of its industry peers.
In the last couple of years the Gross Margin of CMT has grown nicely.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
CMT Yearly Profit, Operating, Gross MarginsCMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMT is creating some value.
The number of shares outstanding for CMT has been reduced compared to 1 year ago.
Compared to 5 years ago, CMT has more shares outstanding
The debt/assets ratio for CMT has been reduced compared to a year ago.
CMT Yearly Shares OutstandingCMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CMT Yearly Total Debt VS Total AssetsCMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.21 indicates that CMT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.21, CMT belongs to the best of the industry, outperforming 90.59% of the companies in the same industry.
The Debt to FCF ratio of CMT is 1.62, which is an excellent value as it means it would take CMT, only 1.62 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CMT (1.62) is better than 91.76% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that CMT is not too dependend on debt financing.
The Debt to Equity ratio of CMT (0.12) is better than 85.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Altman-Z 4.21
ROIC/WACC0.65
WACC8.99%
CMT Yearly LT Debt VS Equity VS FCFCMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.85 indicates that CMT has no problem at all paying its short term obligations.
CMT has a Current ratio of 2.85. This is amongst the best in the industry. CMT outperforms 81.18% of its industry peers.
CMT has a Quick Ratio of 2.36. This indicates that CMT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.36, CMT belongs to the top of the industry, outperforming 83.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.36
CMT Yearly Current Assets VS Current LiabilitesCMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

CMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.18%.
CMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.08% yearly.
The Revenue for CMT has decreased by -15.64% in the past year. This is quite bad
Measured over the past years, CMT shows a small growth in Revenue. The Revenue has been growing by 1.24% on average per year.
EPS 1Y (TTM)-39.18%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-27.4%
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-10.71%

3.2 Future

The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
Based on estimates for the next years, CMT will show a decrease in Revenue. The Revenue will decrease by -0.68% on average per year.
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.47%
Revenue Next 2Y-0.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMT Yearly Revenue VS EstimatesCMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMT Yearly EPS VS EstimatesCMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.70, CMT is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CMT indicates a somewhat cheap valuation: CMT is cheaper than 76.47% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.84, CMT is valued a bit cheaper.
A Price/Forward Earnings ratio of 9.34 indicates a reasonable valuation of CMT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMT indicates a rather cheap valuation: CMT is cheaper than 85.88% of the companies listed in the same industry.
CMT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.29.
Industry RankSector Rank
PE 14.7
Fwd PE 9.34
CMT Price Earnings VS Forward Price EarningsCMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CMT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CMT is cheaper than 92.94% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CMT is valued cheaply inside the industry as 87.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.66
EV/EBITDA 5.2
CMT Per share dataCMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CMT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CMT may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y10.57%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (8/15/2025, 8:12:49 PM)

17.35

-0.12 (-0.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners68.59%
Inst Owner Change4.32%
Ins Owners7.19%
Ins Owner Change3.74%
Market Cap160.66M
Analysts80
Price Target22.44 (29.34%)
Short Float %2.65%
Short Ratio6.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.54%
Min EPS beat(2)-12.99%
Max EPS beat(2)14.08%
EPS beat(4)2
Avg EPS beat(4)-10.99%
Min EPS beat(4)-100%
Max EPS beat(4)54.97%
EPS beat(8)5
Avg EPS beat(8)49.77%
EPS beat(12)8
Avg EPS beat(12)73.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.58%
Min Revenue beat(2)-11.13%
Max Revenue beat(2)3.97%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-11.13%
Max Revenue beat(4)5.25%
Revenue beat(8)5
Avg Revenue beat(8)0.53%
Revenue beat(12)8
Avg Revenue beat(12)3.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-14.89%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-12.96%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)-3.73%
Revenue NY rev (3m)-3.73%
Valuation
Industry RankSector Rank
PE 14.7
Fwd PE 9.34
P/S 0.58
P/FCF 12.66
P/OCF 6.75
P/B 1.05
P/tB 1.22
EV/EBITDA 5.2
EPS(TTM)1.18
EY6.8%
EPS(NY)1.86
Fwd EY10.71%
FCF(TTM)1.37
FCFY7.9%
OCF(TTM)2.57
OCFY14.82%
SpS29.82
BVpS16.57
TBVpS14.27
PEG (NY)1.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROCE 7.49%
ROIC 5.81%
ROICexc 7.64%
ROICexgc 9.05%
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
FCFM 4.6%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexcg growth 3Y14.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Debt/EBITDA 0.71
Cap/Depr 85.03%
Cap/Sales 4.02%
Interest Coverage 12.8
Cash Conversion 89.59%
Profit Quality 135.69%
Current Ratio 2.85
Quick Ratio 2.36
Altman-Z 4.21
F-Score7
WACC8.99%
ROIC/WACC0.65
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.18%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-27.4%
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-10.71%
Revenue Next Year-2.47%
Revenue Next 2Y-0.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.48%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year107.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.49%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y-31.88%
OCF growth 3Y40.98%
OCF growth 5Y16.05%